Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 2
2006 1
2008 2
2013 1
2016 1
2019 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Results by year
Filters applied: . Clear all
Page 1
DTS-108, a novel peptidic prodrug of SN38: in vivo efficacy and toxicokinetic studies.
Meyer-Losic F, Nicolazzi C, Quinonero J, Ribes F, Michel M, Dubois V, de Coupade C, Boukaissi M, Chéné AS, Tranchant I, Arranz V, Zoubaa I, Fruchart JS, Ravel D, Kearsey J. Meyer-Losic F, et al. Clin Cancer Res. 2008 Apr 1;14(7):2145-53. doi: 10.1158/1078-0432.CCR-07-4580. Clin Cancer Res. 2008. PMID: 18381956 Free article.
Preclinical toxicity, toxicokinetics, and antitumoral efficacy studies of DTS-201, a tumor-selective peptidic prodrug of doxorubicin.
Ravel D, Dubois V, Quinonero J, Meyer-Losic F, Delord J, Rochaix P, Nicolazzi C, Ribes F, Mazerolles C, Assouly E, Vialatte K, Hor I, Kearsey J, Trouet A. Ravel D, et al. Among authors: meyer losic f. Clin Cancer Res. 2008 Feb 15;14(4):1258-65. doi: 10.1158/1078-0432.CCR-07-1165. Clin Cancer Res. 2008. PMID: 18281561 Free article.